- Diagnostic Code
- 7719
- CFR Section
- §4.117 — Hemic & Lymphatic
Rating Tiers
100%
Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment
60%
Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission
30%
In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors
What Raters Look For
Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.
M21-1 III.iv.4.G- •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
- •Whether transfusions are required and how frequently
- •Bone marrow biopsy or transplant history
- •Response to treatment and current treatment regimen
- •Constitutional symptoms: fatigue, weight loss, fever